[go: up one dir, main page]

AU2001289726A1 - Use of 13-cis retinoic acid for the treatment of emphysema - Google Patents

Use of 13-cis retinoic acid for the treatment of emphysema

Info

Publication number
AU2001289726A1
AU2001289726A1 AU2001289726A AU8972601A AU2001289726A1 AU 2001289726 A1 AU2001289726 A1 AU 2001289726A1 AU 2001289726 A AU2001289726 A AU 2001289726A AU 8972601 A AU8972601 A AU 8972601A AU 2001289726 A1 AU2001289726 A1 AU 2001289726A1
Authority
AU
Australia
Prior art keywords
emphysema
treatment
retinoic acid
cis retinoic
cis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001289726A
Inventor
Paula Nanette Belloni
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of AU2001289726A1 publication Critical patent/AU2001289726A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/203—Retinoic acids ; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2001289726A 2000-08-02 2001-07-23 Use of 13-cis retinoic acid for the treatment of emphysema Abandoned AU2001289726A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09631151 2000-08-02
US09/631,151 US6339107B1 (en) 2000-08-02 2000-08-02 Methods for treatment of Emphysema using 13-cis retinoic acid
PCT/EP2001/008484 WO2002009679A2 (en) 2000-08-02 2001-07-23 Use of 13-cis retinoic acid for the treatment of emphysema

Publications (1)

Publication Number Publication Date
AU2001289726A1 true AU2001289726A1 (en) 2002-02-13

Family

ID=24529991

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001289726A Abandoned AU2001289726A1 (en) 2000-08-02 2001-07-23 Use of 13-cis retinoic acid for the treatment of emphysema

Country Status (7)

Country Link
US (2) US6339107B1 (en)
EP (1) EP1307187B1 (en)
JP (1) JP2004505036A (en)
AU (1) AU2001289726A1 (en)
DE (1) DE60130661T2 (en)
ES (1) ES2292620T3 (en)
WO (1) WO2002009679A2 (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6720001B2 (en) * 1999-10-18 2004-04-13 Lipocine, Inc. Emulsion compositions for polyfunctional active ingredients
US6339107B1 (en) * 2000-08-02 2002-01-15 Syntex (U.S.A.) Llc Methods for treatment of Emphysema using 13-cis retinoic acid
EP1370238B1 (en) * 2001-03-22 2008-11-12 Battelle Memorial Institute Liquid formulations for electrohydrodynamic spraying containing polymer and suspended particles
DE60219677T2 (en) * 2001-10-30 2008-05-15 Nektar Therapeutics Al, Corp., Huntsville WATER-SOLUBLE POLYMER CONJUGATES OF RETINOIC ACID
US20030185762A1 (en) * 2002-03-22 2003-10-02 Cowan Siu Man L. Highly aqueous liquid carrier formulations
US20040122110A1 (en) * 2002-09-06 2004-06-24 Maccabee Mendy S. Effect of vitamin A gel on paranasal sinus mucosal regeneration
JPWO2006025395A1 (en) * 2004-08-31 2008-05-08 慶彦 清水 Medicine and treatment system for chronic obstructive pulmonary disease using carrier-free cell growth factor
WO2006079209A1 (en) * 2005-01-26 2006-08-03 The University Of British Columbia Pulmonary compositions comprising a vitamin a compound and a surfactant and uses thereof
US20080027031A1 (en) * 2006-03-08 2008-01-31 Kinemed, Inc. Retinoids and Related Compounds for the Treatment of Neuroinflammatory Conditions, Diseases and Disorders
US20070254858A1 (en) * 2006-04-27 2007-11-01 Cronk Peter J Contraceptive and Acne Medication Combination and Treatment of Acne and Other Diseases with Reduced Side Effects
US20070254025A1 (en) * 2006-04-27 2007-11-01 Cronk Peter J Oral contraceptive and acne medication combination and treatment of acne with reduced side effects
US10022348B2 (en) 2009-05-20 2018-07-17 Sun Pharmaceutical Industries Limited Topical solution of isotretinoin
BRPI1010970A2 (en) * 2009-05-20 2019-04-09 Ranbaxy Laboratories Limited pharmaceutical solution, process for preparing a pharmaceutical solution and method for treating
EP3006021A1 (en) 2009-05-20 2016-04-13 Ranbaxy Laboratories Limited Topical retinoid solutions
CN104955444A (en) * 2012-12-27 2015-09-30 微剂量治疗公司 Methods and compositions for administering oxybutynin
JP6826731B2 (en) * 2015-09-10 2021-02-10 国立大学法人 岡山大学 Pharmaceutical composition for the prevention or treatment of inflammatory respiratory diseases
CN113372368B (en) * 2020-03-09 2022-04-12 苏州爱科百发生物医药技术有限公司 A kind of elastase inhibitor prodrug and use thereof
EP4489744A4 (en) * 2022-03-08 2025-11-05 Mastery Biotech Co Ltd Pharmaceutical composition with retinoic acid and carbohydrate and use thereof

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB334585A (en) * 1929-06-06 1930-09-08 British Glues And Chemicals Lt Improvements in or relating to the separation of solids from liquids
ZA791659B (en) 1978-04-17 1980-04-30 Ici Ltd Process and apparatus for spraying liquid
GB8504253D0 (en) 1985-02-19 1985-03-20 Ici Plc Electrostatic spraying apparatus
IL90069A (en) 1988-04-26 1994-04-12 Us Health 13-cis- retinoic acid for use in the preparation of a medicament for treating conglobate and nodulocystic acne
DE3815221C2 (en) 1988-05-04 1995-06-29 Gradinger F Hermes Pharma Use of a retinol and / or retinoic acid ester-containing pharmaceutical preparation for inhalation for acting on the mucous membranes of the tracheo-bronchial tract, including the lung alveoli
GB9116909D0 (en) * 1991-08-06 1991-09-18 Salford Ultrafine Chem & Res Morphine derivatives
TW272187B (en) 1992-05-20 1996-03-11 Hoffmann La Roche
GB9225098D0 (en) 1992-12-01 1993-01-20 Coffee Ronald A Charged droplet spray mixer
GB9226717D0 (en) 1992-12-22 1993-02-17 Coffee Ronald A Induction-operated electro-hydrodynamic spray device with means of modifying droplet trajectories
GB9406255D0 (en) 1994-03-29 1994-05-18 Electrosols Ltd Dispensing device
GB9406171D0 (en) 1994-03-29 1994-05-18 Electrosols Ltd Dispensing device
GB9410658D0 (en) 1994-05-27 1994-07-13 Electrosols Ltd Dispensing device
DE69605025T2 (en) 1995-03-14 2000-07-20 Siemens Ag ULTRASONIC SPRAYER WITH REMOVABLE PRECISION DOSING UNIT
AU701843B2 (en) 1995-03-14 1999-02-04 Siemens Aktiengesellschaft Removable precision dosating unit for ultrasonic atomizer device
US6515022B2 (en) * 1996-04-19 2003-02-04 Sloan-Kettering Institute For Cancer Research Use of inhaled retinoids in the treatment of lung diseases
WO1997039745A1 (en) 1996-04-19 1997-10-30 Sloan-Kettering Institute For Cancer Research Use of inhaled retinoids in the prevention of cancer
US5998486A (en) 1997-07-08 1999-12-07 Georgetown University School Of Medicine Treatment of emphysema with retinoic acid or other retinoids by inducing formation of gas-exchange units (alveoli)
NZ504021A (en) 1997-10-17 2003-04-29 Systemic Pulmonary Delivery Lt Method and apparatus for delivering aerosolized medication having air discharged through air tube directly into plume of aerosolized medication
US6655379B2 (en) 1998-03-16 2003-12-02 Nektar Therapeutics Aerosolized active agent delivery
US6339107B1 (en) * 2000-08-02 2002-01-15 Syntex (U.S.A.) Llc Methods for treatment of Emphysema using 13-cis retinoic acid

Also Published As

Publication number Publication date
EP1307187B1 (en) 2007-09-26
JP2004505036A (en) 2004-02-19
US6794416B2 (en) 2004-09-21
ES2292620T3 (en) 2008-03-16
US20020049252A1 (en) 2002-04-25
US6339107B1 (en) 2002-01-15
EP1307187A2 (en) 2003-05-07
WO2002009679A2 (en) 2002-02-07
DE60130661T2 (en) 2008-07-03
WO2002009679A3 (en) 2002-04-18
DE60130661D1 (en) 2007-11-08

Similar Documents

Publication Publication Date Title
AU2002362482A1 (en) Acne treatment using oleanolic acid
AU2001289726A1 (en) Use of 13-cis retinoic acid for the treatment of emphysema
AU2002358718A1 (en) 2-heteroarylcarboxylic acid amides
AU2001279687A1 (en) Skin conditioning compositions containing compounds for mimicking the effect on skin of retinoic acid
AU2754501A (en) Treatment of acne using lipoic acid
AU2002353219A1 (en) Acid gas removal
AU8991301A (en) New retinoids for the treatment of emphysema
AU2001286983A1 (en) Method of treatment
AU2002243643A1 (en) Estradiol-16alpha-carboxylic acid esters as locally active estrogens
AUPR074500A0 (en) Treatment of t cell disorders
AU2003289171A1 (en) Cosmetic preparation containing glycerylamino acid derivative
AU2001297730A1 (en) Skin whiteners containing hydroxytetronic acid
AU2001242376A1 (en) Process for the preparation of 2-hydroxy-4-methylthiobutyric acid esters
AU2001271134A1 (en) Process for the recovery of shikimic acid
AU2002246926A1 (en) 12-hydroxy-eicosatrienoic acid analogs and methods of use thereof
AU2001262177A1 (en) Method of treatment
AU2002357506A1 (en) Acid-containing preparations
AU2002241944A1 (en) Methods and microorganisms for the production of 3-(2-hydroxy-3-methyl-butyrylamino)-propionic acid (hmbpa)
AU2002333508A1 (en) Method to identify modulators for human 3alpha-hydroxysteroid dehydrogenase
AU2001289723A1 (en) Novel use of difluoromalonic acid esters
AU2001253560A1 (en) Methods of treatment
AU2001237790A1 (en) Method for the preparation of (s)-2-acetylthio-3-phenylpropionic acid
AU2001237791A1 (en) Process for the preparation of (r)-2-bromo-3-phenyl-propionic acid
AU2001260200A1 (en) Novel alpha-sulfin- and alpha-sulfonamino acid amides
AU2001233305A1 (en) Improved method for the manufacture of acrylic acid